Immuneering Corp Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Immuneering Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q3 2024.
  • Immuneering Corp Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.64M, a 10.9% increase year-over-year.
  • Immuneering Corp Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $6.42M, a 25% increase year-over-year.
  • Immuneering Corp annual Share-based Payment Arrangement, Expense for 2023 was $5.73M, a 40.9% increase from 2022.
  • Immuneering Corp annual Share-based Payment Arrangement, Expense for 2022 was $4.06M, a 125% increase from 2021.
  • Immuneering Corp annual Share-based Payment Arrangement, Expense for 2021 was $1.8M, a 65.9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.42M $1.64M +$161K +10.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $5.19M $1.66M +$328K +24.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q2 2024 $600K -$734K -55% May 21, 2024 10-Q 2024-11-13
Q1 2024 $5.93M $1.47M +$201K +15.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $5.73M $1.64M +$592K +56.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 $5.13M $1.48M +$413K +38.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $4.72M $1.33M +$281K +26.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $4.44M $1.27M +$376K +41.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $4.06M $1.05M +$416K +65.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 $3.65M $1.07M +$429K +67.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $3.22M $1.05M +$701K +200% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $2.52M $898K +$715K +393% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $1.8M $633K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 $637K +$326K +105% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $351K +$63.5K +22.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $182K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $310K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $288K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.